Chittagong Medical College
Clinical trials sponsored by Chittagong Medical College, explained in plain language.
-
Could two old drugs beat one for migraine prevention?
Disease control Not yet recruitingThis trial tests whether taking two inexpensive migraine prevention drugs together works better than taking either one alone. Adults aged 18 to 55 who have at least four migraines per month will receive propranolol, flunarizine, or both for 12 weeks. The goal is to see which appr…
Phase: PHASE4 • Sponsor: Chittagong Medical College • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Dialysis drug showdown: which vitamin d works best?
Disease control Not yet recruitingThis study compares two vitamin D medications—doxercalciferol (given through a vein) and calcitriol (taken by mouth)—to see which is better at lowering parathyroid hormone levels in kidney dialysis patients. About 98 adults on dialysis with high parathyroid hormone will take part…
Phase: NA • Sponsor: Chittagong Medical College • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Kidney hope: two-pill combo may slow damage in diabetic patients
Disease control Not yet recruitingThis study compares a two-drug combination (dapagliflozin plus finerenone) against dapagliflozin alone in 88 adults with type 2 diabetes and chronic kidney disease. The goal is to see if the combo better reduces protein in urine, a key sign of kidney damage. Participants take pil…
Phase: PHASE3 • Sponsor: Chittagong Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New heart failure drug trial aims to ease breathing and save lives
Disease control Not yet recruitingThis study tests whether levosimendan, a drug that strengthens heart contractions without increasing oxygen demand, can help people hospitalized with acute decompensated heart failure. About 332 adults will receive either levosimendan plus standard care or standard care alone. Re…
Phase: PHASE2, PHASE3 • Sponsor: Chittagong Medical College • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug could scratch the itch for dialysis patients
Symptom relief Not yet recruitingThis trial tests whether the drug difelikefalin can reduce severe itching in people with chronic kidney disease who are on hemodialysis. About 106 adults will receive either the drug or a placebo after each dialysis session for 6 weeks. The main goal is to see if itching scores i…
Phase: NA • Sponsor: Chittagong Medical College • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC